IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 98 filers reported holding IGM BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,113 | +12.8% | 133,276 | +24.7% | 0.10% | -4.0% |
| Q2 2023 | $987 | +52.3% | 106,918 | +126.6% | 0.10% | +54.7% |
| Q1 2023 | $648 | +27.6% | 47,185 | +58.0% | 0.06% | +1.6% |
| Q4 2022 | $508 | -99.9% | 29,861 | +64.3% | 0.06% | +14.5% |
| Q3 2022 | $413,000 | +4.6% | 18,179 | -17.1% | 0.06% | -6.8% |
| Q2 2022 | $395,000 | -59.5% | 21,917 | -40.0% | 0.06% | -55.0% |
| Q1 2022 | $976,000 | +333.8% | 36,517 | +376.1% | 0.13% | +367.9% |
| Q4 2021 | $225,000 | -36.6% | 7,670 | +41.9% | 0.03% | -22.2% |
| Q3 2021 | $355,000 | -12.8% | 5,405 | +10.4% | 0.04% | -21.7% |
| Q2 2021 | $407,000 | +38.4% | 4,896 | +27.8% | 0.05% | -6.1% |
| Q1 2021 | $294,000 | -49.1% | 3,832 | -41.5% | 0.05% | -48.4% |
| Q4 2020 | $578,000 | – | 6,551 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
| Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
| Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
| Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
| Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
| Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
| Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
| Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
| Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
| Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |